Found 40 matching trials
Belumosudil With Ruxolitnib as Second Line Therapy for Chronic Graft Versus Host Disease (cGvHD) After Steroid Failure PHASE2 Chronic graft-versus-host disease (cGvHD) is a serious condition that can h...
Show More Location
University Health Network
Learn More & Join Trial
A 2-Part, Phase 2 Open-label and Crossover Study of Belumosudil for Treatment of Idiopathic Pulmonary Fibrosis PHASE2 This Phase 2 study is to be conducted to evaluate the safety, tolerability,...
Show More Location
Pulmonary Associates, PA
Learn More & Join Trial
Immunological Tolerance in Patients With Mismatched Kidney Transplants PHASE1 This study seeks to determine if administration of the drug belumosudil (KD...
Show More Status
Active Not Recruiting
Location
University of California, Los Angeles
Learn More & Join Trial
A Clinical Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Belumosudil in Chinese Adolescents With cGVHD Who Have Had an Inadequate Response to Glucocorticoids or Other Systemic Therapies PHASE4 This is a single group, Phase 4, single-arm post-marketing study for treatm...
Show More Location
Investigational Site Number : 1560001
Learn More & Join Trial
Evaluation of Belumosudil Whole Tablets vs. Crushed Tablets Pharmacokinetics in Patients Suffering From Chronic GvHD PHASE1 The primary objective of the study is to evaluate belumosudil pharmacokinet...
Show More Location
The University of Texas M. D. Anderson Cancer Center
Learn More & Join Trial
A Study to Determine the Effect of Multiple Oral Doses of SLx-2119 in Healthy Male Subjects PHASE1 The purpose of this study is to determine the safety, tolerability, and pha...
Show More Location
Investigational site
Learn More & Join Trial
A Safety and Tolerability Study of Belumosudil (KD025) Treatment in Subjects With Moderately Severe Psoriasis Vulgaris PHASE2 The primary objective is to assess the safety and tolerability of 200 mg of...
Show More Location
UC Irvine Health, Dept of Dermatology
Learn More & Join Trial
A Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Chronic Graft Versus Host Disease PHASE2 This study was been conducted to evaluate the safety, tolerability, and act...
Show More Location
City of Hope National Medical Center
Learn More & Join Trial
KD025 in Subjects With Diffuse Cutaneous Systemic Sclerosis PHASE2 This randomized, placebo-controlled phase 2 study was seeking to evaluate t...
Show More Location
Viable Research Management_Site number 131
Learn More & Join Trial
A Prospective Study of Madecassoside Tablets in Sclerotic Chronic Graft-versus-Host Disease After Allo-HSCT PHASE2 Sclerotic chronic graft-versus-host disease (scl-cGVHD) is a severe subtype...
Show More Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial